What are the potential issues associated with Naltrexone (opioid receptor antagonist) use?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Potential Issues with Naltrexone Use

Naltrexone can cause serious hepatotoxicity, precipitate severe opioid withdrawal, and has multiple common side effects including nausea, headache, and psychiatric symptoms that require careful monitoring. 1

Hepatotoxicity Concerns

Naltrexone carries a risk of hepatotoxicity, particularly at higher doses:

  • At standard doses (50mg daily oral), hepatotoxicity is uncommon in patients with normal liver function 1
  • Higher doses (up to 300mg daily) have been shown to cause hepatocellular injury in a substantial proportion of patients 1
  • Transient, asymptomatic hepatic transaminase elevations have been observed in clinical trials 1
  • Patients should be monitored for symptoms of acute hepatitis and discontinue naltrexone if these develop 1

Despite these warnings, several studies have shown that:

  • Naltrexone does not significantly alter liver function at therapeutic doses in patients without pre-existing liver disease 2, 3
  • Even high-dose naltrexone (200mg bid) has been used without adverse liver effects in certain populations 4
  • Naltrexone has been safely used in patients with acute viral hepatitis without exacerbating liver disease 5

Precipitated Opioid Withdrawal

One of the most serious risks with naltrexone is precipitated withdrawal:

  • Naltrexone can precipitate severe withdrawal in patients who are not completely opioid-free 1
  • Symptoms can appear within 5 minutes of ingestion and last up to 48 hours 1
  • Withdrawal may be severe enough to require hospitalization 1
  • Mental status changes including confusion, somnolence, and visual hallucinations can occur 1
  • Significant fluid losses from vomiting and diarrhea may require IV fluid administration 1

To prevent precipitated withdrawal:

  • Patients must be opioid-free for at least 7-10 days before starting naltrexone 6, 1
  • Patients transitioning from buprenorphine or methadone may be vulnerable to withdrawal for up to two weeks 1
  • Naltrexone should be held for 2-3 days prior to elective surgical procedures if opioids are expected to be used perioperatively 6
  • Extended-release naltrexone should be held for 24-30 days before elective procedures requiring opioids 6

Common Adverse Effects

In clinical trials and usage studies, the following adverse effects were commonly reported:

  • Gastrointestinal: nausea (9.8%), vomiting, abdominal pain/cramps, diarrhea 1, 7
  • Neurological: headache (6.6%), dizziness (4%), somnolence (2%) 1, 7
  • Psychiatric: nervousness (4%), anxiety (2%), insomnia (3%), fatigue (4%) 1, 7
  • Musculoskeletal: joint and muscle pain 1

In a large multicenter usage study, 15% of patients discontinued naltrexone due to adverse events, most frequently nausea 7.

Psychiatric Concerns

Naltrexone has been associated with psychiatric symptoms that require monitoring:

  • Depression, suicidal ideation, and suicide attempts have been reported 1
  • Depression rates range from 0-15% with naltrexone (compared to 0-17% with placebo) 1
  • Suicide attempt/ideation rates range from 0-1% with naltrexone (compared to 0-3% with placebo) 1
  • Patients and families should be alerted to monitor for emergence of depression or suicidality 1

Special Considerations

  • Liver disease: Cautious use is recommended in patients with hepatic impairment 6
  • Surgery: Hold oral naltrexone for 2-3 days prior to elective procedures if opioids are expected 6
  • Pain management: Patients on naltrexone may have difficulty achieving adequate analgesia with opioids 6
  • Constipation management: Naltrexone may be useful in combination with opioids to limit constipation, particularly in vulnerable populations like Parkinson's disease and elderly patients 6

Monitoring Recommendations

  • Monitor liver function tests before and periodically during treatment 1
  • Watch for signs of hepatitis (jaundice, abdominal pain, elevated transaminases) 1
  • Screen for depression and suicidal ideation regularly 1
  • Ensure patients are completely opioid-free before initiating treatment 1

By understanding these potential issues with naltrexone use, clinicians can appropriately select patients for treatment, monitor for adverse effects, and manage complications when they arise.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.